| employment, agency or contract related to or supportive of the | provision of health care to individuals. |
|
| | Sec. C-17. 22 MRSA §8702, sub-§8, as enacted by PL 1995, c. 653, Pt. | A, §2 and affected by §7, is amended to read: |
|
| | 8. Payor. "Payor" means a 3rd-party payor or 3rd-party | administrator. |
|
| | Sec. C-18. 22 MRSA §8702, sub-§9-A is enacted to read: |
|
| | 9-A.__Quality data.__"Quality data" means data submitted by | health care providers from which health care service indicators | may be developed and reported to the public. |
|
| | Sec. C-19. 22 MRSA §8702, sub-§11, as amended by PL 2001, c. 677, §2, | is further amended to read: |
|
| | 11. Third-party payor. "Third-party payor" means a health | insurer, nonprofit hospital, medical services organization or | managed care organization licensed in the State or the plan | established in chapter 854. "Third-party payor" does not include | carriers licensed to issue limited benefit health policies or | accident, specified disease, vision, disability, long-term care, | or nursing home care or Medicare supplement policies. |
|
| | Sec. C-20. 22 MRSA §8703, sub-§1, as amended by PL 2001, c. 457, §4, | is further amended to read: |
|
| | 1. Objective. The purpose purposes of the organization is | are to create and maintain a useful, objective, reliable and | comprehensive health information database that is used to improve | the health of Maine citizens and, either independently or in | conjunction with another state entity, to issue periodic reports. | This database must be publicly accessible while protecting | patient confidentiality and respecting providers of care. The | organization shall collect, process and, analyze and report | clinical and, financial and quality data as defined in this | chapter. |
|
| | Sec. C-21. 22 MRSA §8704, sub-§1, ķA, as amended by PL 2001, c. 457, | §7, is further amended to read: |
|
| A. The board shall develop and implement data collection | policies and procedures for the collection, processing, | storage and analysis of clinical, financial and |
|
| restructuring data in accordance with this subsection for | the following purposes: |
|
|